ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic–therapeutic pathway in Italy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic–therapeutic pathway in Italy
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL SUPPLEMENTS
Volume 19, Issue suppl_D, Pages D3-D54
Publisher
Oxford University Press (OUP)
Online
2017-05-03
DOI
10.1093/eurheartj/sux029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey
- (2016) G. Kees Hovingh et al. ATHEROSCLEROSIS
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
- (2016) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2016) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PCSK9 inhibition in type 2 diabetes: so far so good, but not there yet
- (2016) Raul D Santos Lancet Diabetes & Endocrinology
- Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data
- (2016) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Impact of Postdischarge Statin Withdrawal on Long-Term Outcomes in Patients With Acute Myocardial Infarction
- (2015) Min Chul Kim et al. AMERICAN JOURNAL OF CARDIOLOGY
- Frequency of High-Risk Patients Not Receiving High-Potency Statin (from a Large Managed Care Database)
- (2015) Fatima Rodriguez et al. AMERICAN JOURNAL OF CARDIOLOGY
- Primary Risk Prevention in the Elderly: Use Clinician-Patient Discussions, Not Automatic Statin Prescribing
- (2015) Neil J. Stone et al. AMERICAN JOURNAL OF MEDICINE
- PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
- (2015) Miguel Cainzos-Achirica et al. ANNALS OF INTERNAL MEDICINE
- Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia
- (2015) Eliano Pio Navarese et al. ANNALS OF INTERNAL MEDICINE
- Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
- (2015) John R. Downs et al. ANNALS OF INTERNAL MEDICINE
- IMPROVE-IT clinical implications. Should the “high-intensity cholesterol-lowering therapy” strategy replace the “high-intensity statin therapy”?
- (2015) Luis Masana et al. ATHEROSCLEROSIS
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy
- (2015) Carlos Aguiar et al. ATHEROSCLEROSIS SUPPLEMENTS
- Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
- (2015) Viveca Gyberg et al. Cardiovascular Diabetology
- Effect of niacin on lipids and glucose in patients with type 2 diabetes: A meta-analysis of randomized, controlled clinical trials
- (2015) Yi Ding et al. CLINICAL NUTRITION
- Pathophysiology of diabetic dyslipidaemia: where are we?
- (2015) Bruno Vergès DIABETOLOGIA
- PCSK9 Inhibitors and Neurocognitive Adverse Events: Exploring the FDA Directive and a Proposal for N-of-1 Trials
- (2015) Kristopher J. Swiger et al. DRUG SAFETY
- Intensive LDL lowering therapy for prevention of recurrent cardiovascular events: a word of caution
- (2015) Maarten L. Simoons et al. EUROPEAN HEART JOURNAL
- The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
- (2015) Michael J. Lipinski et al. EUROPEAN HEART JOURNAL
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trials
- (2015) James McKenney et al. Journal of Clinical Lipidology
- Lowering LDL Cholesterol Is Good, but How and in Whom?
- (2015) Neil J. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Drugs for Treating Dyslipidemia: Beyond Statins
- (2015) Chang Ho Ahn et al. Diabetes & Metabolism Journal
- Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe
- (2015) Julian P. Halcox et al. PLoS One
- Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)
- (2014) Daniel Gaudet et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effectiveness of Combination Therapy With Statin and Another Lipid-Modifying Agent Compared With Intensified Statin Monotherapy
- (2014) Kimberly A. Gudzune et al. ANNALS OF INTERNAL MEDICINE
- Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
- (2014) Mary A. De Vera et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Lomitapide and Mipomersen
- (2014) Daniel J. Rader et al. CIRCULATION
- Bile Acid Sequestrants: Glucose-Lowering Mechanisms and Efficacy in Type 2 Diabetes
- (2014) Morten Hansen et al. Current Diabetes Reports
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
- (2014) Barbara Sjouke et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
- (2014) Frederick J. Raal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Secondary prevention after acute myocardial infarction: Drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry
- (2014) Stefano Urbinati et al. European Journal of Preventive Cardiology
- Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study
- (2014) Barbara Sjouke et al. Lancet Diabetes & Endocrinology
- The Complexity of Measuring Clinical Complexity
- (2013) Barbara J. Turner et al. ANNALS OF INTERNAL MEDICINE
- Defining Patient Complexity From the Primary Care Physician's Perspective
- (2013) Richard W. Grant et al. ANNALS OF INTERNAL MEDICINE
- Defining Patient Complexity
- (2013) Richard W. Grant ANNALS OF INTERNAL MEDICINE
- Defining Patient Complexity
- (2013) Joseph M. Cerimele ANNALS OF INTERNAL MEDICINE
- Treating Our Societal Scotoma: The Case for Investing in Geriatrics, Our Nation's Future, and Our Patients
- (2013) Rosanne M. Leipzig ANNALS OF INTERNAL MEDICINE
- New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
- (2013) Amirhossein Sahebkar et al. CARDIOVASCULAR DRUGS AND THERAPY
- Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective
- (2013) Amir Hooshang Mohammadpour et al. CLINICAL PHARMACOKINETICS
- Niacin
- (2013) Henry N. Ginsberg et al. CURRENT OPINION IN LIPIDOLOGY
- 2013 ESC guidelines on the management of stable coronary artery disease
- (2013) EUROPEAN HEART JOURNAL
- Diagnosis and treatment of familial hypercholesterolaemia
- (2013) G. Kees Hovingh et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease
- (2013) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
- (2013) Philippa J Talmud et al. LANCET
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
- (2013) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward a Modern Mediterranean Diet for the 21st Century
- (2013) J. Stamler NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study
- (2013) Christopher Ll Morgan et al. BMJ Open
- PCSK9 Inhibitors: Potential in Cardiovascular Therapeutics
- (2013) Rose Q. Do et al. Current Cardiology Reports
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Exercise effects on lipids in persons with varying dietary patterns—does diet matter if they exercise? Responses in Studies of a Targeted Risk Reduction Intervention through Defined Exercise I
- (2012) Kim M. Huffman et al. AMERICAN HEART JOURNAL
- In This Issue: Assessing and Acting on Complexity
- (2012) K. C. Stange ANNALS OF FAMILY MEDICINE
- Association of Patient-Centered Outcomes With Patient-Reported and ICD-9-Based Morbidity Measures
- (2012) E. A. Bayliss et al. ANNALS OF FAMILY MEDICINE
- A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology
- (2012) M. Fortin et al. ANNALS OF FAMILY MEDICINE
- Measures of Multimorbidity and Morbidity Burden for Use in Primary Care and Community Settings: A Systematic Review and Guide
- (2012) A. L. Huntley et al. ANNALS OF FAMILY MEDICINE
- A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2
- (2012) Raul D. Santos et al. ATHEROSCLEROSIS
- Healthy Lifestyle Through Young Adulthood and the Presence of Low Cardiovascular Disease Risk Profile in Middle Age
- (2012) Kiang Liu et al. CIRCULATION
- Design of Tumor Biomarker-Monitoring Trials: A Proposal by the European Group on Tumor Markers
- (2012) G. Soletormos et al. CLINICAL CHEMISTRY
- ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK
- (2012) Kornelia Kotseva et al. HEART
- Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey
- (2012) Raffaele Griffo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study
- (2012) Ola Vedin et al. European Journal of Preventive Cardiology
- Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes
- (2011) Lutgarda Bozzetto et al. ATHEROSCLEROSIS
- Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era
- (2011) Lawrence D. Lazar et al. CIRCULATION
- Heart Disease and Stroke Statistics—2012 Update
- (2011) et al. CIRCULATION
- Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats
- (2011) Vipin Dhote et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study
- (2011) Alessandro Nobili et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
- (2011) Anne C. Goldberg et al. Journal of Clinical Lipidology
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence and Coexistence of Cardiovascular Comorbidities among the US Dyslipidemic Population Aged ≥ 65 Years by Lipid-Lowering Medication Use Status
- (2011) Sean D. Candrilli et al. POSTGRADUATE MEDICINE
- Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia
- (2010) Fatima Akdim et al. AMERICAN JOURNAL OF CARDIOLOGY
- Apolipoprotein A-I Mimetic Peptides
- (2010) Courtney B. Sherman et al. Cardiology in Review
- Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
- (2010) Donald M. Lloyd-Jones et al. CIRCULATION
- Italian cardiovascular mortality charts of the CUORE project: are they comparable with the SCORE charts?
- (2010) Chiara Donfrancesco et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation
- (2010) Massimo Francesco Piepoli et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular risk in women with diabetes
- (2010) A.A. Rivellese et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Explaining the Decrease in Coronary Heart Disease Mortality in Italy Between 1980 and 2000
- (2009) Luigi Palmieri et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease
- (2009) Andrew Mente et al. ARCHIVES OF INTERNAL MEDICINE
- Medication Adherence
- (2009) P. Michael Ho et al. CIRCULATION
- EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
- (2009) Kornelia Kotseva et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Complexity and health - yesterday's traditions, tomorrow's future
- (2009) Joachim P. Sturmberg et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
- (2008) Alexander Kulik et al. CIRCULATION
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Discontinuation of statin therapy following an acute myocardial infarction: a population-based study
- (2008) S. S. Daskalopoulou et al. EUROPEAN HEART JOURNAL
- Statins in liver disease: A molehill, an iceberg, or neither?
- (2008) Curtis K. Argo et al. HEPATOLOGY
- Statins for Secondary Prevention in Elderly Patients
- (2008) Jonathan Afilalo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening
- (2008) J M Reich THORAX
- The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment
- (2007) M. Andrikoula et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation